Literature DB >> 25638648

Policy trends and reforms in the German DRG-based hospital payment system.

Uwe Klein-Hitpaß1, David Scheller-Kreinsen2.   

Abstract

A central structural point in all DRG-based hospital payment systems is the conversion of relative weights into actual payments. In this context policy makers need to address (amongst other things) (a) how the price level of DRG-payments from one period to the following period is changed and (b) whether and how hospital payments based on DRGs are to be differentiated beyond patient characteristics, e.g. by organizational, regional or state-level factors. Both policy problems can be and in international comparison often are empirically addressed. In Germany relative weights are derived from a highly sophisticated empirical cost calculation, whereas the annual changes of DRG-based payments (base rates) as well as the differentiation of DRG-based hospital payments beyond patient characteristics are not empirically addressed. Rather a complex set of regulations and quasi-market negotiations are applied. There were over the last decade also timid attempts to foster the use of empirical data to address these points. However, these reforms failed to increase the fairness, transparency and rationality of the mechanism to convert relative weights into actual DRG-based hospital payments.
Copyright © 2015 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  Baserate; DRG; Germany; Hospital; Price; Reform

Mesh:

Year:  2015        PMID: 25638648     DOI: 10.1016/j.healthpol.2015.01.006

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  9 in total

1.  Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.

Authors:  Juri Katchanov; Kai Wöstmann; Daniela Tominski; Laura Jefferys; Anna Liedtke; Arnim Schneider; Hortense Slevogt; Keikawus Arastéh; Hartmut Stocker
Journal:  Infection       Date:  2015-08-27       Impact factor: 3.553

2.  Impact of payment system change from per-case to per-diem on high severity patient's length of stay.

Authors:  Sung-In Jang; Chung Mo Nam; Sang Gyu Lee; Tae Hyun Kim; Sohee Park; Eun-Cheol Park
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

3.  Charting a path forward: policy analysis of China's evolved DRG-based hospital payment system.

Authors:  Rui Liu; Jianwei Shi; Beilei Yang; Chunlin Jin; Pengfei Sun; Lingfang Wu; Dehua Yu; Linping Xiong; Zhaoxin Wang
Journal:  Int Health       Date:  2017-09-01       Impact factor: 2.473

4.  Impacts of Hospital Payment Based on Diagnosis Related Groups (DRGs) with Global Budget on Resource Use and Quality of Care: A Case Study in China.

Authors:  Suwei Yuan; Wenwei Liu; Fengqing Wei; Haichen Zhang; Suping Wang; Weijun Zhu; Jin Ma
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

5.  Are cost differences between specialist and general hospitals compensated by the prospective payment system?

Authors:  Francesco Longo; Luigi Siciliani; Andrew Street
Journal:  Eur J Health Econ       Date:  2017-10-23

6.  Forecasting Single Disease Cost of Cataract Based on Multivariable Regression Analysis and Backpropagation Neural Network.

Authors:  Fang Qing; Chuang Liu
Journal:  Inquiry       Date:  2019 Jan-Dec       Impact factor: 1.730

7.  Big Data-Enabled Analysis of DRGs-Based Payment on Stroke Patients in Jiaozuo, China.

Authors:  Dawei Qiao; Yanru Zhang; Ateeq Ur Rehman; Mohammad R Khosravi
Journal:  J Healthc Eng       Date:  2020-12-02       Impact factor: 2.682

8.  The Use of Diagnosis-Related Group-Based Reimbursement in the Czech Hospital Care System.

Authors:  Zuzana Kotherová; Martina Caithamlová; Juraj Nemec; Kateřina Dolejšová
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

9.  Diagnosis-Related Groups' Payment Reform in Beijing.

Authors:  Wei-Ping Jiao
Journal:  Chin Med J (Engl)       Date:  2018-07-20       Impact factor: 2.628

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.